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Abstract
 
Lymphocytes home to peripheral lymph nodes (PLNs) via high endothelial venules (HEVs) in
the subcortex and incrementally larger collecting venules in the medulla. HEVs express ligands
for L-selectin, which mediates lymphocyte rolling. L-selectin counterreceptors in HEVs are
recognized by mAb MECA-79, a surrogate marker for molecularly heterogeneous glycans
termed peripheral node addressin. By contrast, we find that medullary venules express L-selectin
ligands not recognized by MECA-79. Both L-selectin ligands must be fucosylated by 
 
 
 
(1,3)-
 
fucosyltransferase (FucT)-IV or FucT-VII as rolling is absent in FucT-IV
 
 
 
VII
 
    
 
mice. Intravital
microscopy experiments revealed that MECA-79–reactive ligands depend primarily on FucT-VII,
whereas MECA-79–independent medullary L-selectin ligands are regulated by FucT-IV.
Expression levels of both enzymes paralleled these anatomical distinctions. The relative mRNA
level of FucT-IV was higher in medullary venules than in HEVs, whereas FucT-VII was most
prominent in HEVs and weak in medullary venules. Thus, two distinct L-selectin ligands are
segmentally confined to contiguous microvascular domains in PLNs. Although MECA-79–
reactive species predominate in HEVs, medullary venules express another ligand that is spatially,
antigenically, and biosynthetically unique. Physiologic relevance for this novel activity in
medullary microvessels is suggested by the finding that L-selectin–dependent T cell homing to
PLNs was partly insensitive to MECA-79 inhibition.
Key words: homing • intravital microscopy • leukocyte adhesion • leukocyte rolling • 
vascular addressin
 
Introduction
 
Endothelial cells (ECs) in postcapillary and small collecting
venules support adhesion and diapedesis of circulating leu-
kocytes, whereas capillaries or arterioles in most organs are
essentially nonadhesive. Venules in most lymphoid and
some nonlymphoid organs constitutively express adhesion
molecules, so-called vascular addressins, and chemokines
normally not found in other vascular beds (1). Because
vascular addressins are tissue specific, i.e., they are either by
themselves or in combination unique to the specialized
venular ECs in a particular organ, they regulate the magni-
tude and composition of leukocyte populations that enter
that organ (1, 2). Although some molecular pathways for
organ-specific homing of circulating leukocytes are well
understood, the cellular and molecular mechanisms that
induce and sustain endothelial specialization and vascular
addressin expression are still largely unknown.
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Abbreviations used in this paper:
 
 BCECF, 2
 
  
 
7
 
 
 
,-bis-(2-carboxyethyl)-5 (and 6)
carboxyfluorescein; EC, endothelial cell; FucT, 
 
 
 
(1,3)-fucosyltransferase;
HEV, high endothelial venule; IVM, intravital microscopy; LOV, low
order venule; NR, Nile red; PLN, peripheral LN; PNAd, peripheral
node addressin; sLeX, sialyl-Lewis
 
x
 
; TRITC, tetramethylrhodamine-5-
isothiocyanate; YG, yellow green.T
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The best understood example of endothelium-con-
trolled subset-specific leukocyte recruitment is the homing
of lymphocytes to peripheral LNs (PLNs; 3–5). PLNs are
strategically positioned to collect antigen via afferent lym-
phatics, which drain lymph from the periphery into the
subcapsular sinus (1, 6). Professional antigen-presenting
cells migrate via lymphatics from peripheral tissues into
PLNs to interact with lymphocytes. B cells are concen-
trated within follicles in the PLN cortex, whereas T cells
reside in the subcortex and paracortex. Most lymphocytes
that home to PLNs and fail to encounter their cognate an-
tigen leave the node by migrating through the medulla
into efferent lymph vessels (7).
Blood vessels in different anatomic regions of PLNs pos-
sess distinct properties. Typical murine PLNs are supplied by
a small artery that penetrates the capsule near the hilus and
emits arteriolar branches toward the cortex (8). Arterioles
give rise to capillary networks, which merge in the T cell
area into high endothelial venules (HEVs) ranging in diame-
ter from 
 
 
 
15–50 
 
 
 
m. HEVs merge into collecting venules
lined by flat endothelium in the medulla (9). From here,
blood is channeled through hilar vessels into an extranodal
vein. The entire venular tree can be visualized by intravital
microscopy (IVM) of murine subiliac LNs (superficial in-
guinal) (8). This structure consists of up to five branching
orders where the low order venules (LOVs) comprise a large
collecting venule in the hilus (order I) and upstream
branches in the medulla (order II and some order III). High
order branches are HEVs constituting most order III and all
order IV and V venules (8).
Lymphocyte homing occurs mainly in high order HEVs
(3, 4). The first step is the binding of L-selectin (CD62L) to
endothelial sulfated carbohydrate (CHO) ligands. L-selec-
tin–mediated adhesion is characterized by high on-rate and
tensile strength, allowing free-flowing lymphocytes to
tether in the presence of shear. Tethered cells roll slowly
downstream until they are stimulated by the chemokines
CCL21 or CXCL12, which activate LFA-1 integrins whose
engagement allows for firm arrest and diapedesis (3–5).
L-selectin is critical for lymphocyte homing to PLNs
(10, 11). L-selectin ligands in HEVs are a heterogeneous set
of glycan-based structures termed peripheral node addressin
(PNAd), which are recognized by mAb MECA-79 (12,
13). The MECA-79 antigen is a core 1–linked, 6-sulfated,
sialyl-Lewis
 
x 
 
(sLeX)-like, O-glycan that decorates several
endothelial sialomucins, including CD34, GlyCAM-1,
podocalyxin, and spg200 (14–17). For L-selectin ligand
function, PNAd must be sialylated, sulfated, and 
 
 
 
(1,3)-
fucosylated (18–22). Thus, PNAd is the result of HEV-spe-
cific posttranslational events involving several glycosyltrans-
ferases and at least one sulfotransferase.
Required enzymes for PNAd function in vivo are
 
 
 
(1,3)-fucosyltransferase (FucT)-IV, FucT-VII, and the
sulfotransferase HEC-GlcNAc6ST (also called LSST or
GST-3; 20–22). 
 
 
 
(1,3)-fucosylation is particularly essential
because homing is abolished in mice that lack both FucT-
IV and FucT-VII (22). Although FucT-VII is important for
selectin ligand generation (21), homing in FucT-VII
 
 
 
/
 
 
 
mice is less affected than in FucT-IV
 
 
 
VII
 
 
 
/
 
  
 
mice, indi-
cating that FucT-IV compensates partially for FucT-VII
deficiency (22). Treatment of mice with mAb MECA-79
inhibits lymphocyte homing to PLNs (12). However,
homing is only moderately reduced (
 
 
 
50%) in HEC-
GLCNAC6ST
 
 
 
/
 
  
 
mice despite the lack of luminal
MECA-79 reactivity in HEVs (20). Thus, MECA-79–
reactive PNAd may not be the only endothelial structure
recognized by L-selectin in PLN venules.
Here, we provide evidence that LOVs in mouse subiliac
LNs express functional L-selectin ligand(s) that are spatially
and antigenically distinguishable from MECA-79–reactive
PNAd. The MECA-79–reactive material is restricted to
paracortical and subcortical venules (order III–V), whereas
L-selectin ligand(s) in medullary LOVs are MECA-79
 
 
 
.
Moreover, the medullary L-selectin ligand activity is regu-
lated largely by FucT-IV, which is more highly expressed
in LOVs than elsewhere in PLNs.
 
Materials and Methods
 
Antibodies and Reagents.
 
Antibodies to murine L-selectin
(Mel-14), PNAd (MECA-79), sialyl-Lewis
 
X/A 
 
(HECA-452),
ICAM-2 (mIc2/3c4; provided by T.A. Springer, CBR Institute
for Biomedical Research), and human L-selectin (DREG-200)
were purified according to standard procedures. FITC-conju-
gated anti–mouse or rat IgM and IgG (Zymed Laboratories) were
used for flow cytometry. Tetramethylrhodamine-5-isothiocyan-
ate (TRITC), 2
 
  
 
7
 
 
 
,-bis-(2-carboxyethyl)-5 (and 6) carboxyfluo-
rescein (BCECF), rhodamine 6G, and fluorescent polystyrene
microbeads were purchased from Molecular Probes. FITC-dex-
tran was from Sigma-Aldrich.
 
L1-2 Cell Preparation and Labeling.
 
Murine L1-2 pre–B lym-
phoma cells transfected with human L-selectin (L1-2
 
L-selectin
 
; ref-
erence 13) were grown in RPMI 1640 containing 10% FCS
(cRPMI), 250 
 
 
 
g/ml mycophenolic acid, 12.5 
 
 
 
g/ml xanthine,
and 1X hypoxanthine/thymidine (GIBCO BRL). For experi-
ments, transfectants that expressed between 70,000 and 100,000
L-selectin molecules/cell were labeled with 2.5 
 
 
 
g/ml BCECF
for 30 min.
 
Flow Cytometry.
 
To assess surface expression of L-selectin on
L1-2
 
L-selectin 
 
transfectants, cells were labeled with 20 
 
 
 
g/ml mAb
DREG-200 followed by FITC-conjugated anti–mouse IgG, and
analyzed using a FACScan™ flow cytometer (BD Biosciences).
L-selectin expression was quantified as previously described (23).
 
Animals.
 
Young adult FucT-deficient mice and WT litter-
mates (C57B1/6 
 
  
 
129SV) were used (21, 22). T-GFP trans-
genic mice were generated in our laboratory (24). Mice were
kept in a viral antibody-free, specific pathogen-free barrier facil-
ity. Experimental procedures were approved by Animal Commit-
tees of both Harvard Medical School and The Center for Blood
Research in accordance with National Institutes of Health (NIH)
guidelines.
 
Surgical Preparation of Subiliac LN.
 
Mice were anesthetized by
intraperitoneal injection of 1 mg/ml xylazine and 5 mg/ml ket-
amine. The left subiliac LN was prepared for IVM as previously
described, and the right femoral artery was catheterized for retro-
grade injection of fluorescent dyes, cells, beads, or mAbs (8). The
preparation was transferred to a customized intravital video mi-
croscopy setup (Mikron Instruments) equipped with water im-
mersion objectives (Carl Zeiss MicroImaging, Inc.). FluorescentT
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events in the LN microcirculation were visualized by video-trig-
gered stroboscopic epi-illumination (Chadwick Helmuth), re-
corded by a silicon-intensified target camera (VE1000SIT; Dage
MTI), and stored on Hi8 video tape.
 
Assessment of Intravascular Cell Behavior.
 
Endogenous leuko-
cyte interactions with vascular endothelium were visualized by
injection of 1 mg/ml rhodamine 6G (3). In some experiments,
100 
 
 
 
g mAb Mel-14 or MECA-79 (10 mg/kg body weight)
were injected i.v., and leukocyte behavior was recorded 15 min
thereafter. To visualize L1-2
 
L-selectin 
 
transfectants, BCECF-labeled
cells were injected as previously described (8). Luminal surface
area of PLN microvessels was calculated from the diameter and
length of individual vascular segments (assuming cylindrical ge-
ometry) after injection of 150 kD FITC-dextran.
Cell behavior in PLN venules was assessed as previously de-
scribed (3, 4, 8). The rolling fraction was determined as the per-
centage of cells that rolled along the vascular lining in the total
flux of cells per venule. Rolling cells that arrested for at least 30 s
were considered firmly adherent, and their number per luminal
surface area was calculated for each venule. Velocity analysis was
performed by frame by frame analysis of two representative vessels
per experiment as previously described (8). Trajectories of indi-
vidual cells were traced during passage through capillaries and
venules, and their displacement from the point where they first
entered the field of view was measured for every video frame.
The instantaneous velocity of rolling cells, i.e., the displacement
between subsequent video frames (1/30 s), was measured over up
to 160 video frames and plotted as a function of time.
 
In Vivo Mapping of Antigen Densities in PLN Venular Trees.
 
Distribution of MECA-79
 
  
 
and MECA-79
 
  
 
venules in PLNs was
assessed by injecting CFSE-MECA-79 (1 mg/kg body weight),
which leads to specific accumulation of fluorescent mAb in HEV
within 10–15 min (25). For semiquantitative assessment of endo-
thelial surface antigen density and distribution in PLN microves-
sels, protein A–coated yellow green (YG; Ex/Em: 505/515 nm)
and Nile red (NR; Ex/Em: 535/575 nm) fluorescent micro-
spheres (1 
 
 
 
m diameter) were labeled with 80 
 
 
 
g/ml anti–rat
IgG or IgM. YG beads were incubated with 80 
 
 
 
g/ml MECA-
79, HECA-452, or anti–ICAM-2. NR beads were incubated
with isotype-matched control mAb. Binding of NR beads in
PLN microvessels was recorded 15 min after i.v. injection. After
NR beads had disappeared from the circulation (within 30 min),
an equivalent amount of YG beads was injected and binding was
recorded in the same vessels.
Control experiments performed with control mAb-coated
beads revealed no preferential accumulation in particular venular
branching orders. To account for random and somewhat variable
background binding, bound control NR beads and Ag-specific
YG beads were enumerated throughout the entire PLN venular
tree (NR
 
PLN 
 
and YG
 
PLN
 
, respectively). For the specific accumula-
tion of YG beads, YG
 
sp 
 
was determined as YG
 
sp 
 
  
 
YG
 
PLN
 
  
 
NR
 
PLN
 
,
and the specific binding constant (c) was c 
 
  
 
YG
 
sp
 
/YG
 
PLN 
 
  
 
100
(%). From the density of adherent YG beads per luminal surface
area in each individual venular segment, YG
 
ven
 
, the specific venu-
lar concentration, [YG
 
ven
 
], was calculated as: [YG
 
ven
 
] 
 
  
 
YG
 
ven
 
 
 
 
 
c (mm
 
 
 
2
 
). The specific arteriolar concentration [YG
 
art
 
] was calcu-
lated accordingly.
 
Homing Experiments.
 
Lymphocyte homing was studied using
donor cells from T-GFP mice in which PLN-tropic (i.e., naive
and central memory) T cells express GFP, whereas other leuko-
cytes are GFP
 
  
 
(24, 26). 2 
 
  
 
10
 
7 
 
T-GFP PLN cells were injected
i.v. into recipient mice. After 2 h, mice were killed and single cell
suspensions were prepared from pooled bilateral subiliac, axillary,
 
and brachial PLNs. The frequency of homed GFP
 
  
 
T cells was
determined by flow cytometry as previously described (4). In
some experiments, donor cells were labeled with 30 
 
 
 
g/ml
TRITC and homed B cells (GFP
 
  
 
TRITC
 
 
 
) and T cells (GFP
 
 
 
TRITC
 
 
 
) were enumerated. To assess the role of MECA-79–
reactive and MECA-79–nonreactive L-selectin ligands, three mice
received i.v. injections of either 100 
 
 
 
g mAb Mel-14, 10 mg/kg
mAb MECA-79, or sterile saline. 15 min later, animals received
2 
 
  
 
10
 
7 
 
T-GFP cells and PLNs were harvested 2 or 24 h thereaf-
ter. The number of homed GFP
 
  
 
cells per 10
 
6 
 
injected cells was
determined for each recipient. Homing in mAb-treated mice was
expressed relative to the control mouse that received the same
donor cells.
 
Sorting of PLN ECs.
 
PLNs (inguinal, axillary, brachial, cervi-
cal, and popliteal) were collected from 60 young adult C57Bl/6
mice. Single cell suspensions prepared after type II collagenase
treatment (Worthington Biochemical Corp.) were depleted of
leukocytes using anti-CD45 paramagnetic microbeads (MACS;
Miltenyi Biotec). Unbound cells were washed and stained using
anti–CD45-CyChrome, anti–MECA79-PE, anti–P-selectin–Ig
(BD Biosciences) followed by anti–human Fc-FITC (Caltag), and
anti–CD31-biotin (BD Biosciences) followed by streptavidin-
ECD (Coulter Immunotech). CD45
 
  
 
CD31
 
  
 
ECs from LOVs
(MECA-79
 
  
 
P-selectin-Ig
 
 
 
), HEVs (MECA-79
 
  
 
P-selectin-Ig
 
 
 
),
and nonvenular ECs (MECA-79
 
  
 
P-selectin-Ig
 
 
 
) were sorted us-
ing an EPICS Elite ESP cell sorter (Coulter Corp.).
 
Analysis of FucT Expression by RT-PCR.
 
EC mRNA was iso-
lated from sorted LOVs (7,630 cells), HEVs (11,500 cells), and
nonvenular vessels (20,200 cells) using an RNeasy Mini Kit
(QIAGEN). After digesting genomic DNA, cDNA was gener-
ated using oligo dT/dNTP mixture (PerkinElmer) with or with-
out Superscript II Reverse Transcriptase (GIBCO BRL). cDNA
corresponding to 
 
 
 
1,000 cells/sample was used in each PCR re-
action (Hot Star TAq kit; QIAGEN).
Two pairs of primers were added for simultaneous amplifica-
tion of cDNA pairs for FucT-IV, FucT-VII, and 
 
 
 
-actin. Primer
sequences (5
 
 
 
-3
 
 
 
) were as follows: FucT-IV sense: TGGACG-
CGTGGCGAGCCGCGGTGGCCACTCGTGGA, FucT-IV
antisense: AACACGCGTAGTACCAGCGCCTTATCCGTG-
CGTTC; FucT-VII sense: CCTCTCTCTGGGCCCACATC-
CCCACTACCG, FucT-VII antisense: TCATAGACCTGGC-
TGCGGGGCAAGTAAGGG; and 
 
 
 
-actin sense: TTGGG-
TATGGAATCCTGTGGCATCCATGAAAC, 
 
 
 
-actin anti-
sense: TAAAACGCAGCTCAGTAACAGTCCGCCTAGAA.
PCR amplification was performed on five replicates/sample:
step 1, 95
 
 
 
C for 15 min; step 2, 94
 
 
 
C for 1 min; step 3, 70
 
 
 
C for
1 min; step 4, 72
 
 
 
C for 1 min. Steps 2–4 were repeated 39 times.
At the end of cycles 31, 33, 35, and 37, one replicate tube from
each sample was incubated for 10 min at 72
 
 
 
C. Samples were run
on a 4% acrylamide gel in TBE buffer containing ethidium bro-
mide. Empirical analysis of digital images of amplified bands using
Adobe Photoshop 6.01 software revealed that samples that under-
went 37 amplification cycles yielded optimal results for compari-
son of relative band intensities. Band intensities were determined
as the median channel number in intensity histograms in fixed
size regions set over each band. The background fluorescence was
determined for each lane and subtracted from specific band signals
in the same lane. Relative signal intensity ratios were calculated
by dividing the median intensity channel of the larger amplicon
by that of the smaller one.
 
Statistics.
 
For statistical comparison of two samples, a two-
tailed Student’s 
 
t
 
 test was used. Multiple comparisons were per-
formed using the Kruskal-Wallis test with Bonferroni correction.T
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Differences were considered statistically significant when P  
0.05. Data are presented as mean   SEM.
Online Supplemental Material. Video 1 illustrates the topogra-
phy of MECA-79–reactive L-selectin ligands in a mouse PLN.
Videos 2–4 document the behavior of L1-2 cells in a PLN.
Video 5 shows an animated three-dimensional reconstruction of
serial confocal sections through a subiliac LN 24 h after treat-
ment with mAb MECA-79 and adoptive transfer of green
fluorescent T cells.  Fig. S1 is a schematic diagram of the
microvascular anatomy shown in Videos 2–4. Videos 1–5 and
Fig. S1 are available at http://www.jem.org/cgi/content/full/
jem.20030182/DC1.
Results and Discussion
L-Selectin Ligands Are Expressed in Both MECA-79 
HEVs and MECA-79  LOVs. Previous IVM observa-
tions of murine subiliac LNs illustrate a striking distinction
between different segments of the venular tree with regard
to reactivity with CFSE-labeled anti-PNAd mAb MECA-
79 (25). After i.v. injection of fluorescent mAb, paracortical
and subcortical postcapillary and small collecting venules
(orders III–V) were brightly stained, whereas most large
collecting LOVs in the medulla (orders I–II) were not (Fig.
1 A). Because MECA-79–reactive glycans are considered
the critical L-selectin ligands in PLNs, LOVs should sup-
port little or no L-selectin–mediated rolling. However, pri-
mary mouse lymphocytes and stably transfected L1-2L-selectin
cells rolled in order I and II venules, albeit at a lower fre-
quency than in high order venules (3, 8, 25, 27).
We examined this apparent discrepancy between seg-
mentally confined MECA-79 reactivity, and broad venular
L-selectin ligand activity using L1-2L-selectin  transfectants.
CFSE-labeled MECA-79 was injected at a dose (20  g/
mouse) sufficient to label MECA-79  microvessels, but less
Figure 1. EC adhesiveness and ex-
pression of MECA-79 epitope changes
abruptly on transition from capillaries to
HEVs. (A) CFSE-MECA-79 staining of
two venular trees (a and b) in a subiliac
PLN (left), with major anatomic features
illustrated schematically (right). Blood
enters PLN capillaries (not visible) via
branches of the superficial epigastric artery
(Art). Postcapillary and small collecting
HEVs (orders III–V, light gray) are
MECA-79 , but low order medullary
venules (LOV, orders I–II, dark gray)
and extra-lymphoid veins (ELV) are not.
The PLN is surrounded by connective
tissue (CT).  40. (B) PLN subcortex
showing capillary network (arrows indi-
cate direction of blood flow) draining
into an order V HEV (hatched). CFSE-
MECA-79 delineates the sharp transition
from capillaries to HEV (T   0 s). A
fluorescent lymphocyte (arrowhead)
passes through a capillary at high velocity
(T   0.5 – 0.8 s), tethers to MECA-79 
ECs (T   1.2 s), and rolls slowly along
the HEV (T   7.4 s). The capillary net-
work was subsequently visualized by
injecting FITC-dextran (not depicted).
 400. (C) Displacement histograms of
three L1-2L-selectin cells (R1, R2, and R3)
during transition from capillaries into
HEVs. A cell enters the field of view at
time 0. The distance of the cell to the
transition from MECA-79   ECs to
MECA-79  HEVs was determined for
every video frame until the cell disap-
peared from the field of view. (D) Instan-
taneous velocity histograms of L1-2L-selectin
cells, R1–R3, shown in C during their
passage through capillaries and
HEVs.  See also Video 1, available at
http://www.jem.org/cgi/content/full/
jem.20030182/DC1.T
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than necessary for inhibition of L-selectin binding in high
order venules (see below). Consistent with previous studies
(8, 27), many L1-2L-selectin cells rolled in high order venules
immediately after entry from capillaries (Fig. 1, B–D),
whereas control transfectants did not.
MECA-79 staining ended abruptly in LOVs, seemingly
between adjacent ECs. Loss of immunoreactivity often co-
incided with vessel bifurcations, but occasionally staining
disappeared midway along an order II or III venule, unre-
lated to any other apparent anatomic features (Fig. 2 A).
The rolling fraction of L1-2L-selectin cells was highest in order
IV and V venules, decreasing further downstream as the
rolling cells detached and rejoined the fast moving blood
stream (8, 27). However, detachment occurred throughout
the venular tree and did not coincide with the disappear-
ance of MECA-79 staining. Indeed, L1-2L-selectin cells con-
tinued rolling as they passed from MECA-79  to MECA-
79  LOVs, without appreciable immediate changes in ve-
locity (Fig. 2 B). L-selectin–mediated rolling is relatively
jerky (28), which was somewhat more apparent in MECA-
79  than MECA-79  venules (Fig. 2 C). However, as is
typical for microvascular leukocyte behavior, there was
considerable heterogeneity even within MECA-79  venu-
lar segments because the immediate postcapillary venules
supported smoother and slower rolling than most down-
stream venules.
Segmental Differences in Adhesion Molecule Expression be-
tween Different Branching Orders in PLN Venules. The roll-
ing behavior of L1-2L-selectin cells together with the CFSE-
MECA-79 staining pattern suggested the existence of
Figure 2. L-selectin transfectants roll
throughout the PLN venular tree despite
discontinuous expression of MECA-79
epitopes. (A) Micrographs illustrating
the abrupt transition from MECA-79 
to MECA-79  ECs in PLN venules in a
segment of venular tree a in Fig. 1 A
(top panel;  100), and an order III
venule from a different preparation
(bottom panel;  200). Transition from
MECA-79  to MECA-79  ECs (black
arrowheads) often coincided with venular
bifurcations (top panel), but was also
seen within continuous venular segments
(bottom panel). White arrows indicate
direction of blood flow. (B) Displace-
ment histograms of two noninteracting
fast cells (F1 and F2) and three rolling
cells (R1–R3) in MECA-79   and
MECA-79   segments of the same
venule. Cells were analyzed as in Fig. 1
C. (C) Instantaneous velocity histograms
of the three rolling cells, R1–R3, shown
in panel B.T
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MECA-79–insensitive L-selectin ligand(s) in LOVs. To
eliminate the possibility of a low density MECA-79–reac-
tive ligand that was undetectable using video microscopy,
we established a more sensitive, semiquantitative assay to
analyze luminal surface antigens in PLNs. Polystyrene
beads (1  m diameter) emitting either YG or NR fluores-
cence were coated with mAbs against endothelial adhesion
molecules or control mAbs, respectively. Equivalent num-
bers of beads were successively injected into mice and
branching order-specific bead accumulation was deter-
mined in PLNs (Fig. 3).
MECA-79–coated beads mirrored fluorescent mAb la-
beling, as there was a dramatic accumulation of beads in
high order venules, whereas bead binding was very sparse in
order II and undetectable in order I venules. Anti-sLeX/A–
coated beads were similarly distributed, with some addi-
tional binding in order I. Neither set of beads bound to ar-
terioles or arteries, whereas beads coated with anti–ICAM-1
or anti–ICAM-2 adhered to these microvessels. Anti-
ICAM beads also bound to PLN venules, but at relatively
low density and without preference for any particular
branching order. Nevertheless, anti–ICAM-1– and anti–
ICAM-2–coated beads accumulated 2.7- and 2.1-fold
more than control beads, a ratio that was in the same range
as seen with beads to P-selectin or VCAM-1 in bone mar-
row microvessels (29).
It should be cautioned that differences in bead accumula-
tion between mAbs may not necessarily reflect different ab-
solute densities of endothelial antigens. Factors including
the number of functional binding sites per bead, mAb affin-
ity, avidity, and accessibility of cognate epitopes are impor-
tant. For example, MECA-79 and HECA-452 are mul-
tivalent IgMs recognizing CHO-capping groups in the
endothelial glycocalyx, whereas anti–ICAM-1 and anti–
ICAM-2 are bivalent IgGs that bind epitopes on the core
of glycoproteins located close to the cell membrane. Nev-
ertheless, this assay provides a relative measure of the intra-
vascular accessibility and relative abundance of endothelial
surface molecules in the microcirculation.
Because anti-ICAM–coated beads showed no statistically
significant preference for any particular venular order, the
skewedness in MECA-79– and anti-sLeX/A –coated bead
distribution toward high order venules cannot be explained
by segmentally distinct microhemodynamics. Rather, the
findings indicate that MECA-79–reactive glycans are only
expressed in high order venules and are absent from LOVs.
sLeX/A has a similar distribution, but is expressed at a low
level in order I venules.
MECA-79 Blocks L-Selectin Tethering Only in High Order
PLN Venules. Because LOVs are devoid of MECA-79
reactivity, but support L-selectin binding, we postulated
that MECA-79 treatment should not affect rolling in
LOVs. Saturating amounts of MECA-79 (10 mg/kg) nearly
abolished rolling of L1-2L-selectin cells in high order venules,
but reduced rolling in LOVs only slightly (Fig. 4 A). This
partial inhibition by MECA-79 in LOVs was not necessar-
ily caused by locally expressed MECA-79 antigen because
most cells that rolled in LOVs initially tethered in upstream
MECA-79  segments (Fig. 2, B and C). If margination in
high order venules is prevented by MECA-79, fewer cells
are likely to interact downstream even if LOVs express dif-
ferent L-selectin ligand(s). Indeed, MECA-79 had no sig-
nificant effect when only those L1-2L-selectin cells that were
free flowing in high order venules and initiated rolling after
entering LOVs were taken into account (Fig. 4 B).
These findings indicate that MECA-79–reactive L-selec-
tin ligands are restricted to high order venules, whereas
L-selectin binding to LOVs is mediated by a second, anti-
genically distinct L-selectin ligand. The nearly complete in-
hibition of rolling by MECA-79 in high order venules sug-
gests that the two L-selectin ligands have distinct spatial
expression patterns with little overlap along the venular tree.
MECA-79–independent L-Selectin Ligands Mediate T Cell
Homing to PLNs. We tested the relative contribution of
MECA-79–reactive and nonreactive L-selectin ligands to
lymphocyte homing in PLNs. We used T-GFP mice in
which PLN-tropic naive and central memory T cell subsets
express GFP (4, 26, 30). Consistent with recent findings
(31), treatment with MECA-79 abrogated T cell accumu-
lation in WT PLNs at 2 h (Fig. 4 C). However, short-term
homing may not be sufficiently sensitive to detect subtle
contributions by other ligands. Indeed, after 24 h, PLNs
in MECA-79–treated recipients contained 83.7    4.5%
Figure 3. Fluorescent bead accumulation in PLNs reveals segmental
differences in luminal antigen expression between venular branching orders.
Binding of nonspecific mAb-coated NR and specific mAb-coated YG
fluorescent beads in PLN microvessels 15 min after i.v. injection. NR
beads were injected first, followed by an equivalent number of YG beads
coated with mAb MECA-79, anti-sLeX/A (HECA-452), anti–ICAM-1, or
anti–ICAM-2. The accumulation of specific beads was calculated as described
in Materials and Methods. All specific mAb-coated beads bound signifi-
cantly more than control beads, except for MECA-79–coated beads in
order I venules, and both MECA-79 and anti-sLeX/A–coated beads in
arterioles. *, P   0.05; **, P   0.01; ***, P   0.001 compared with order
I venules. Number of LNs/venules analyzed: 9/54 for ICAM-1; 3/46 for
ICAM-2; 5/77 for sLeX/A; and 4/45 for MECA-79.T
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(mean   SEM) fewer homed cells than in control mice,
compared with 98.6   0.2% inhibition with anti–L-selec-
tin (P   0.05; n   4 mice/group).
Serum MECA-79 decreased from 30  g/ml at 2 h to 5
 g/ml at 24 h after a single injection. To increase the mAb
concentration at 24 h, two mice received an additional in-
jection of 10 mg/kg MECA-79 12 h after T cell transfer,
resulting in 27  g/ml MECA-79 at 24 h. Despite these dif-
ferent blood levels, T cell homing was equivalent (82 vs.
86% inhibition), indicating that both treatment regimens
achieved maximal inhibition of homing.
T cells that homed to PLNs of MECA-79–treated recip-
ients were not trapped in microvessels but resided through-
out the T cell area, some in the vicinity of LOVs (Fig. 4
D). Because homed T cells migrate rapidly and in random
directions as soon as they have passed across HEVs (32), lo-
calization of homed cells may not necessarily reflect the mi-
crovascular segment in which they became initially ad-
herent. Nevertheless, these data strongly suggest that a
significant fraction of L-selectin–dependent T cell homing
to PLNs is insensitive to MECA-79 inhibition.
L-Selectin–mediated Rolling Has Distinct Requirements for
FucT-IV and FucT-VII in High Order Venules and LOVs.
Although physiologic selectin ligands require  (1,3)-fuco-
sylation by FucT-VII and, to a lesser degree, by FucT-IV,
the MECA-79 epitope is not fucosylation dependent (21,
22, 33, 34). Recent work has shown that MECA-79
epitopes are associated with core 1–linked O-glycans
whose intravascular expression depends on 6-sulfation of a
GlcNAc residue by the HEV-specific sulfotransferase,
HEC-GLCNAC6ST (17, 20, 31). Nevertheless, fucosyla-
tion is essential for L-selectin ligand function in PLN HEVs
because lymphocyte homing is markedly reduced (by
 80%) in PLNs of FucT-VII    mice, and the homing de-
fect is significantly more severe in FucT-IV VII    doubly
deficient mice (22). To assess the role of fucosylation for
Figure 4. Effect of MECA-79 on
L-selectin–dependent lymphocyte homing
and rolling in PLNs. (A) The rolling frac-
tion of L1-2L-selectin cells was analyzed before
and after MECA-79 treatment (10 mg/kg
i.v.) in each branching order of PLN venu-
lar trees (n     6 mice). mAb treatment
blocked rolling in order II–V venules (**,
P   0.01; ***, P   0.001 vs. no mAb), but
had minimal effect in order I venules. (B)
Tethering fraction of L1-2L-selectin cells in
order I and II venules before and after
PNAd inhibition. Only free-flowing cells
that established the first adhesive contact
with LOVs were counted. See also Videos
2–4, available at http://www.jem.org/cgi/
content/full/jem.20030182/DC1. (C) L-selec-
tin–mediated  homing of naive T cells to
PLNs is partially insensitive to MECA-79
inhibition. MECA-79 treatment (10 mg/kg,
15 min before T cell injection) abrogated T
cell homing to PLNs harvested 2 h after cell
injection (n   2). 24 h of treatment with
MECA-79 (15 min before and 12 h after T
cell injection) reduced homing significantly
less than anti–L-selectin mAb Mel-14 (100
 g/mouse). Results were normalized to
untreated control mice. n   4 mice/group;
*, P   0.05 versus 24 h MECA-79. (D) 3-D
reconstruction of serial confocal micro-
graphs showing homed T cells (green) in in-
guinal LNs 24 h after treatment with saline
(top), anti–L-selectin mAb Mel-14 (middle),
or MECA-79 (bottom). The intravascular
compartment was delineated by i.v. injection
of TRITC-dextran (red). Numerous extravas-
cular T cells are dispersed throughout control
and MECA-79–treated PLNs, including in
the vicinity of LOVs (order I and II
venules). A nearby extralymphoid vein
drains blood from the node. LN borders are
demarcated by white lines. See also Video
5, available at http://www.jem.org/cgi/
content/full/jem.20030182/DC1.T
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L-selectin ligand(s) in LOVs, we compared the rolling behav-
ior of rhodamine 6G-labeled circulating leukocytes in each
venular order in PLNs of WT and FucT-deficient mice.
As expected, rolling was completely absent in FucT-
IV VII    PLNs, indicating that all L-selectin ligands are
obligatorily   (1,3)-fucosylation dependent (Fig. 5 A).
However, the relative importance of FucT-IV and FucT-
VII depended on anatomic localization. In high order
venules rolling was predominantly dependent on FucT-
VII. Some residual rolling was observed in HEVs of FucT-
VII    mice, but not in doubly deficient PLNs, indicating a
minor role of FucT-IV. This FucT-IV–dependent ligand
activity was blocked by MECA-79 treatment (Fig. 4 A and
unpublished data). However, because MECA-79 is an IgM
of relatively high molecular weight (12) and accumulates to
high density in HEVs, we cannot exclude that FucT-IV
generates L-selectin ligand(s) that are structurally distinct
from the MECA-79 antigen, but still inhibitable by
MECA-79 possibly due to steric hindrance.
Unexpectedly, rolling in LOVs was similar in WT and
FucT-VII    PLNs and significantly increased in FucT-
IV    PLNs. Anti–L-selectin mAb Mel-14 abrogated roll-
ing in all venules of both FucT-IV    and FucT-VII   
PLNs, indicating that deletion of FucT genes did not in-
duce compensatory up-regulation of other rolling pathways
(Fig. 5 B). Anti–L-selectin inhibited leukocyte rolling in
mutant mice even more completely than in WT animals
where P-selectin mediates some L-selectin–independent
rolling (35). This is expected because FucT-IV and FucT-
VII contribute to P-selectin ligand generation (22, 36). En-
hanced rolling observed in LOVs of FucT-IV    PLNs was
due to the absence of FucT-IV in ECs, not leukocytes, as
lymphocytes from WT and FucT-IV     donors rolled
equivalently in FucT-IV    PLNs (unpublished data).
Together, these findings imply segmentally distinct en-
zyme requirements for venular L-selectin ligand generation.
Although FucT-VII predominates in high order venules
where the MECA-79 epitope is strongly expressed, FucT-
IV prevails in LOVs because rolling was minimally affected
in medullary venules of FucT-VII    PLNs. However,
FucT-VII can also generate L-selectin ligands in LOVs be-
cause rolling was significantly enhanced in FucT-IV   
LOVs, but completely lost in FucT-IV VII    PLNs.
Naive T Cell Homing Is Enhanced in PLNs of FucT-IV   
Mice. Because FucT-IV deficiency unexpectedly boosted
L-selectin–dependent rolling in LOVs, we sought to deter-
mine the physiologic significance of this observation for
lymphocyte homing. Earlier studies using a mixture of na-
ive and memory B and T cells from mesenteric LNs found
a trend toward increased homing in FucT-IV    PLNs, but
this was not statistically significant (22). Because different
lymphocyte populations have distinct PLN tropism (30,
37), the inherent variability in homing of mixed lympho-
cyte populations might obscure subset-specific effects in
FucT-IV    PLNs. Therefore, we stained T-GFP lympho-
cytes with the red fluorophore TRITC for subset-specific
homing studies in PLNs of WT, FucT-IV   , or FucT-
VII    recipients.
Figure 5. Role of FucT-IV and
FucT-VII in lymphocyte homing and
L-selectin ligand activity in PLN
venules. (A) Rolling fractions of
rhodamine 6G-labeled leukocytes were
assessed in each venular order of PLN
from WT and mutant mice. Rolling was
absent in FucT-IV VII     PLNs.
Compared with WT mice, rolling in
FucT-VII    PLNs was markedly lower
in order III–V HEVs, modestly decreased
in order II, and unchanged in order I
venules. Rolling in order I–III venules
of FucT-IV    PLNs was significantly
higher than in WT PLNs, whereas rolling
in order IV and V venules was similar. *,
P   0.05; **, P   0.01; ***, P   0.001
versus WT. (B) Leukocyte rolling in
FucT-IV     and FucT-VII     PLNs
before and after injection of anti–
L-selectin (100  g/mouse). ***, P  
0.001  versus control; n     3 mice/
group. (C) Compared with WT mice,
naive T cell homing was enhanced in
FucT-IV    mice and severely compro-
mised in FucT-VII    mice. *, P   0.05
versus WT; ***, P   0.001 versus WT
and FucT-IV   ;  n     4 mice/group.
(D) B cell homing required FucT-VII
and was somewhat increased in FucT-
IV    PLNs (P   0.05). ***, P   0.001
versus WT and FucT-IV   ;  n     4
mice/group.T
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As predicted by our IVM studies and consistent with
previous reports (21, 22), both GFP  TRITC  T cells (Fig.
5 C) and GFP  TRITC  B cells (Fig. 5 D) homed poorly
to FucT-VII    PLNs (P   0.001). Strikingly, FucT-IV   
PLNs contained  87% more donor T cells than WT PLNs
(P   0.05). Average B cell homing was also 67% higher in
FucT-IV    PLNs, but this was quite variable (P   0.05).
Thus, FucT-IV exerts an attenuating effect on T cell hom-
ing to PLNs, presumably by reducing availability of
L-selectin ligands in LOVs. On the other hand, homing is
more severely compromised in FucT-IV VII    PLNs
than in FucT-VII    PLNs (22), indicating an additional
adhesion-promoting role for FucT-IV–dependent glycans,
at least in FucT-VII    mice, which was also confirmed by
our IVM studies. Given the prominent role of FucT-IV in
L-selectin ligand production in LOVs, it seems likely that
MECA-79–insensitive L-selectin ligands in these vessels
can contribute to the physiologic entry of lymphocytes into
WT PLNs. Accordingly, we observed L-selectin–depen-
dent, MECA-79–insensitive T cell homing to PLNs in
FucT-IV    mice, which was somewhat more pronounced
than in WT mice (Fig. 4 C).
Selectin Ligand Activity in LOVs Is Transcriptionally Deter-
mined by the Balance of FucT-IV and FucT-VII Expression.
To explain why FucT-IV deficiency increases FucT-VII–
dependent L-selectin ligand activity in LOVs, one must
consider the acceptor preferences of FucT-IV and FucT-
VII (38, 39). FucT-VII requires  (2,3)-sialylated terminal
lactosamine to generate sLeX-like selectin ligands. FucT-IV
can also use the sialylated lactosamine substrate, albeit less
efficiently than FucT-VII. However, unlike FucT-VII,
FucT-IV additionally fucosylates internal GlcNAc residues
in polylactosamine (38) and uses nonsialylated lactosamine
to generate LewisX-like structures (22), which do not inter-
act with selectins. Thus, FucT-IV may compete with
 (2,3)sialyltransferase(s) and/or FucT-VII for terminal lac-
tosamine as a shared precursor substrate on O-linked gly-
cans. Consequently, FucT-IV may divert some terminal lac-
tosamine acceptor moieties toward the Lewisx pathway that
does not yield L-selectin ligands, and thus away from the
 (2,3)sialyltransferase/FucT-VII synthetic route. In LOVs
of WT mice, FucT-IV could thus attenuate FucT-VII–
dependent production of sLeX-based L-selectin ligands.
Without FucT-IV, increased acceptor availability for
 (2,3)sialyltransferase/FucT-VII permits increased selectin
ligand production, whereas FucT-VII deficiency might
have lesser impact because sLeX-based L-selectin ligands
could still be generated if FucT-IV is abundantly expressed.
Given these considerations, we hypothesized that venu-
lar L-selectin ligands in PLNs are regulated, in part, by the
balance of FucT-IV and FucT-VII expression. FucT-VII is
transcriptionally regulated by diverse external factors. It is
induced postnatally in developing murine PLN HEVs. In
adult PLNs, FucT-VII expression is transiently down-regu-
lated upon antigenic challenge, and afferent lymph flow is
essential for steady-state expression (40). Whether endothe-
lial FucT-IV is also subjected to spatial and/or temporal
regulation has not been examined.
Based on a combination of EC-specific antigenicity
(CD45  CD31 ) and differential selectin ligand expression,
we sorted three distinct EC populations from PLNs (Fig. 6
A): (a) nonvenular MECA-79  ECs (from capillaries, some
arterioles, and possibly lymphatics) that did not express
selectin ligands, (b) MECA-79   ECs from high order
venules, and (c) MECA-79  ECs from LOVs expressing
selectin ligands. To identify the latter, we exploited the fact
that PLN venules support not only binding of L-selectin,
but also P-selectin and E-selectin (27, 41). Indeed, both
P-selectin  activated platelets and L1-2P-selectin transfectants
tethered and rolled efficiently in LOVs, but not in capillar-
ies or arterioles (unpublished data). Thus, LOV ECs were
defined as MECA-79  CD45  CD31  cells that bound
P-selectin–Ig chimeric protein. Substituting P-selectin–Ig
for L-selectin–Ig facilitated this approach, because L-selec-
Figure 6. Differential expression of FucT-IV and FucT-VII in PLN
ECs. (A) Leukocyte-depleted cell suspensions from PLNs of 60 WT
mice were stained for the pan-leukocyte antigen CD45, MECA-79,
pan-endothelial CD31, and P-selectin–Ig chimera ligands. After gating
on large cells (R1), ECs from high order venules were identified as
CD45  MECA-79  (R3) as well as CD31  and P-selectin–Ig binding
(P-lig ; not depicted). ECs from other vascular segments were isolated
from the CD45  MECA-79  fraction (R2) by gating on CD31  cells.
P-lig  ECs were from LOVs (R4), and nonvenular ECs (MECA-79 
P-lig ) were from capillaries, arterioles, and possibly lymph vessels (R5).
(B) mRNA from equivalent numbers of sorted ECs from LOVs (lanes 1–3),
high order venules (lanes 4–6), and nonvenular vessels (lanes 7–9) was
subjected to RT-PCR with and without addition of reverse transcriptase
(RT) followed by competitive PCR amplification (37 cycles) of pairs of
cDNAs for FucT-IV, FucT-VII, and the housekeeping gene  -actin. The
intensity ratios of amplified bands in each lane are shown. Intensity ratios
could not be determined (ND) in lanes 8 and 9 because no specific signal
for FucT-VII transcripts was detectable in nonvenular ECs. The PCR
procedure was repeated twice with similar results.T
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tin–Ig yielded poor staining (unpublished data), presumably
due to the shorter bond lifetime and/or the more pro-
nounced requirement for fluid shear that distinguish
L-selectin from P-selectin bonds (28, 42, 43).
EC subsets were sorted from PLNs pooled from 60 do-
nor mice, which yielded a total of 11,500 ECs from HEVs,
7,500 LOV ECs, and 20,200 nonvenular ECs. Subse-
quently, sorted cells were lysed and subjected to multiplex
RT-PCR. Each PCR reaction contained cDNA from
equivalent numbers of cells, and two pairs of primers for si-
multaneous amplification of FucT-IV, FucT-VII, and/or
 -actin. Digital images of amplicon bands were measured
by densitometry. Although this approach did not allow di-
rect quantitation of absolute mRNA levels, signal intensity
ratios for each pair of amplicons could be reasonably deter-
mined. Thus, we generated a side by side comparison of
FucT-IV and FucT-VII expression relative to each other
and to  -actin in each EC population (Fig. 6 B).
The results of this semiquantitative analysis, which was re-
peated twice with similar results, were in excellent agree-
ment with our hypothesis. FucT-IV was present in all EC
samples, but relative to  -actin its expression in nonvenular
endothelium was  27 and  6 times lower than in LOVs
and high order venules, respectively. In contrast, FucT-VII
was only detectable in venular ECs and, compared with
 -actin, FucT-VII mRNA was 3.6 times more abundant in
high order venules than in LOVs. Strikingly, the FucT-IV/
FucT-VII ratio was 5.7 times higher in LOVs than in HEVs.
Topography and Biochemistry of L-Selectin Ligands in PLNs.
Assuming that  -actin expression is invariable in PLN ECs, a
map of the relative expression levels of FucT-IV and FucT-
VII can be generated (Fig. 7). FucT-IV predominates in
LOVs where it may generate primarily nonsialylated fucosy-
lated glycans, limiting production to one (or possibly more)
sialylated L-selectin ligand(s) that is (are) antigenically distinct
from the MECA-79 epitope. Although the precise structure
of this molecule remains to be solved, the absence of rolling
in FucT-IV VII    mice shows a clear requirement for
 (1,3) fucosylation. In the absence of FucT-IV, activity of
this ligand is enhanced possibly due to increased substrate
availability for FucT-VII. However, FucT-IV probably
dominates the physiologic ligand generation because FucT-
VII deficiency had minimal impact on LOV adhesiveness.
Whether the medullary L-selectin ligand requires sulfa-
tion for normal activity is unclear. In animals deficient in
HEC-GlcNAc6ST, an HEV-expressed sulfotransferase re-
quired for luminal expression of MECA-79 epitopes,
L-selectin–dependent lymphocyte homing to PLNs is re-
duced by  50%, and lymphocytes roll in all venules at nor-
mal frequency, but with accelerated velocity (20, 31). This
confirms that HEC-GlcNAc6ST–dependent sulfation (and
luminal MECA-79 expression) is important, but not essen-
tial for L-selectin ligand expression in PLNs. We demon-
strate that MECA-79–independent L-selectin ligands are
not merely a peculiarity of HEC-GlcNAc6ST    PLNs,
but they also facilitate T cell rolling and homing in WT
PLNs. MECA-79–insensitive L-selectin binding was also
observed in human tonsils (44). This activity was resistant
to digestion with O-sialoglycoprotease, which destroys si-
alomucins that present MECA-79 epitopes. Conceivably,
medullary L-selectin ligands may not only differ from
MECA-79–reactive ligands in their antigenicity and topog-
raphy, but also in the scaffold on which they are presented.
The sialomucin CD43 antagonizes L-selectin–dependent
T cell tethering and rolling in PLNs (25). This antiadhesive
effect is greater in LOVs than high order HEVs. This sug-
gests that the ultrastructure and/or microenvironment of
medullary L-selectin ligands differ from those in high order
venules, thus allowing large, anionic surface molecules such
as CD43 to exert increased antiadhesive activity in LOVs.
Interestingly, FucT-VII modifies only glycoproteins, whereas
FucT-IV also generates sLeX-containing glycolipids that
support L-selectin binding in vitro (45, 46). Because rolling
on glycolipids requires a closer proximity of surface mem-
branes, it might be more sensitive to interference by CD43.
However, whether FucT-IV–dependent glycolipids can
support in vivo L-selectin binding in LOVs or elsewhere
remains to be determined.
Venular ECs in many nonlymphoid vascular beds express
L-selectin ligands when exposed to inflammation (47, 48),
including heparin-like molecules, which do not require fu-
cosylation for functional activity (49). Moreover, expression
of nonlymphoid endothelial L-selectin ligands is delayed
(about 1 h) in response to inflammatory stimuli (50). Con-
versely, we observed rolling of endogenous leukocytes, iso-
lated lymphocytes, and L1-2L-selectin cells in LOVs immedi-
ately after surgical preparation of PLNs ( 20 min after the
initial skin incision), which was constant over several hours
(unpublished data). Thus, although it cannot be excluded
that the medullary L-selectin ligand(s) described here share(s)
biochemical properties with L-selectin ligands elsewhere, its
spatial restriction and constitutive expression in LOVs
strongly suggest that this activity is unique to PLN medulla.
Figure 7. Distribution of functional L-selectin ligands and of FucT-IV
and FucT-VII in PLN microvessels.T
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Although the medulla is arguably the least understood
region in PLNs, its cellular composition is distinct from
cortical regions. The medulla contains columns of macro-
phages, plasma cells, and T cells of mostly memory pheno-
type. It is assumed that these cells migrate to the medulla
from other regions through the PLN parenchyma. Alterna-
tively, some of these relatively rare leukocytes might be re-
cruited via medullary venules, which we show here to con-
stitute a specialized microvascular environment expressing
at least one unique leukocyte traffic molecule. However,
L-selectin alone would not be sufficient for leukocyte
homing to the medulla because L-selectin allows cells only
to roll, but not arrest. For this, an integrin-activating
chemoattractant and endothelial integrin ligands are neces-
sary. For example, in PLN HEVs, integrin activation on
rolling T and B cells is mediated by CCL21 and CXCL12
(4, 5). Monocytes also home to PLNs that drain inflamed
tissues via CCL2 transported to PLNs via afferent lymph
vessels, and presented in HEVs to stimulate integrin-medi-
ated monocyte arrest (51). Interestingly, our previous IVM
observations using fluorescent mAbs to CCL21 or fluores-
cent CCL2 indicate that these chemokines are not tightly
restricted to HEVs, but are present in medullary venules
(unpublished data). Moreover, significant segmental differ-
ences were not revealed in expression of ICAM-1 and
ICAM-2 within the venular tree (Fig. 3). Thus, all pre-
requisite components of multistep adhesion cascades are
present in medullary venules. However, the magnitude,
composition, and physiologic significance of cellular traffic
through these microvessels must be further examined.
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